Literature DB >> 16523688

[Adequate system for investigation of translation initiation of the human retrotransposon L1 mRNA in vitro].

S E Dmitriev, N V Bykova, D E Andreev, I M Terenin.   

Abstract

Retrotransposon L1 codes for a unique dicistronic mRNA which serves both a transposition intermediate and a template for the synthesis of two proteins of this mobile element. According to preliminary data, the translation initiation of both cistrons of L1 occurs by non-canonical mechanisms. When translating the L1 mRNA in rabbit reticulocyte lysate (RRL), a standard system routinely used by many researchers to study mechanisms of translation initiation in eukaryotes, we observed along with expected products a number of polypeptides resulted from aberrant initiation at internal AUG codons. Such products are absent on translation of L1 mRNA in vivo. Addition to the system of a cytoplasmic extract from HeLa cells resulted in disappearance of these abberant products whereas the efficiency of translation of the first cistron remained unchanged. The level of translation of the second cistron became significantly lower. This also made the picture closer to that observed in vivo. These and other experiments allowed us to clearly demonstrate that the new combined cell-free system is much more adequate to study mechanisms of translation initiation than a regular RRL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523688     DOI: 10.1134/s0026893306010055

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  20 in total

1.  Frequencies of single-nucleotide polymorphisms and mutations in the BRCA1 gene in patients with hereditary breast or ovarian cancer.

Authors:  A V Karpukhin; N I Pospekhova; L N Lubchenko; A N Loginova; E V Khomich; A V Budilov; A S Sergeev; V M Zakhar'ev; R F Gar'kavtseva; E K Ginter
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

2.  [Biochip development for polymorphism analysis in biotransformation system genes].

Authors:  a S Glotov; T V Nasedkina; T E Ivashchenko; R A Iurasov; S A Surzhikov; S V Pan'kov; A V Chudinov; V S Baranov; A S Zasedatelev
Journal:  Mol Biol (Mosk)       Date:  2005 May-Jun

3.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

4.  [Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. Petersburg].

Authors:  N A Grudinina; V I Golubkov; O S Tikhomirova; T V Brezhneva; K P Hanson; V B Vasilyev; M Y u Mandelshtam
Journal:  Genetika       Date:  2005-03

5.  Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.

Authors:  B Csokay; L Tihomirova; A Stengrevics; O Sinicka; E Olah
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

6.  The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

Authors:  Kelly A Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo A Olivotto; William D Foulkes; Ellen Warner; Olufunmilayo Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; Steven A Narod
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

7.  Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Authors:  Hanne Meijers-Heijboer; Cecile T M Brekelmans; Marian Menke-Pluymers; Caroline Seynaeve; Astrid Baalbergen; Curt Burger; Ellen Crepin; Ans W M van den Ouweland; Bert van Geel; Jan G M Klijn
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

8.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

View more
  5 in total

1.  Negative-sense virion RNA of segment 8 (NS) of influenza a virus is able to translate in vitro a new viral protein.

Authors:  O P Zhirnov; K A Akulich; A V Lipatova; E V Usachev
Journal:  Dokl Biochem Biophys       Date:  2017-05-17       Impact factor: 0.788

2.  Efficient translation initiation directed by the 900-nucleotide-long and GC-rich 5' untranslated region of the human retrotransposon LINE-1 mRNA is strictly cap dependent rather than internal ribosome entry site mediated.

Authors:  Sergey E Dmitriev; Dmitri E Andreev; Ilya M Terenin; Ivan A Olovnikov; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

3.  Eukaryotic translation elongation factor 2 (eEF2) catalyzes reverse translocation of the eukaryotic ribosome.

Authors:  Denis Susorov; Nikita Zakharov; Ekaterina Shuvalova; Alexander Ivanov; Tatiana Egorova; Alexey Shuvalov; Ivan N Shatsky; Elena Alkalaeva
Journal:  J Biol Chem       Date:  2018-02-16       Impact factor: 5.157

Review 4.  A researcher's guide to the galaxy of IRESs.

Authors:  Ilya M Terenin; Victoria V Smirnova; Dmitri E Andreev; Sergey E Dmitriev; Ivan N Shatsky
Journal:  Cell Mol Life Sci       Date:  2016-11-16       Impact factor: 9.207

5.  Differential contribution of the m7G-cap to the 5' end-dependent translation initiation of mammalian mRNAs.

Authors:  Dmitri E Andreev; Sergey E Dmitriev; Ilya M Terenin; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.